PROSTAP 3, also known as Leuprorelin or Leuprolide acetate, is a type of medication used primarily in the treatment of hormone-sensitive cancers such as prostate cancer in men and breast cancer in women, as well as conditions like endometriosis and uterine fibroids. It belongs to a class of drugs known as gonadotropin-releasing hormone (GnRH) agonists, which work by reducing the amount of testosterone in men and estrogen in women. This reduction in hormone levels can help to slow the growth of hormone-sensitive tumors and alleviate symptoms of conditions like endometriosis. PROSTAP 3 is administered through an injection, typically once every three months, making it a convenient option for long-term treatment plans. Its use, however, must be closely monitored by healthcare professionals due to potential side effects and the need for dosage adjustments based on the patient's response to therapy.